# Cevimeline in Treating Patients With Dry Mouth Caused by Radiation Therapy for Head and Neck Cancer

> **NCT00017511** · PHASE3 · COMPLETED · sponsor: **Daiichi Sankyo**

## Conditions studied

- Head and Neck Cancer
- Oral Complications
- Radiation Toxicity

## Interventions

- **DRUG:** cevimeline hydrochloride

## Key facts

- **NCT ID:** NCT00017511
- **Lead sponsor:** Daiichi Sankyo
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2001-06
- **Primary completion:** 2003-03
- **Final completion:** 2003-03
- **Target enrollment:** — (—)
- **Last updated:** 2012-05-16


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00017511

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00017511, "Cevimeline in Treating Patients With Dry Mouth Caused by Radiation Therapy for Head and Neck Cancer". Retrieved via AI Analytics 2026-06-15 from https://api.ai-analytics.org/clinical/NCT00017511. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*